IGF-1 LR3 1mg
Long R3 Insulin-like Growth Factor-1
≥99.0%
Third-Party
COA
Complete your research kit
Also searched as: LR3-IGF-1, Long R3 IGF
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 (IGF-1) supplied as a research material for controlled laboratory investigation. Also known as Long R3 IGF-1, the peptide has structural modifications that distinguish it from endogenous IGF-1 and make it useful for studying IGF signalling, receptor interactions and cellular responses. IGF-1 LR3 Australia research is primarily associated with experimental work involving growth-factor signalling, cell biology and metabolic pathways.
What Is IGF-1 LR3?
IGF-1 LR3 is an engineered analogue of IGF-1. Its structure incorporates an arginine substitution at position three together with an extended N-terminal peptide sequence.
These modifications influence its interaction with IGF-binding proteins compared with native IGF-1. This characteristic has made Long R3 IGF-1 useful as an experimental tool for investigating IGF-related biological processes under controlled research conditions.
IGF-1 signalling is primarily associated with the insulin-like growth factor 1 receptor (IGF-1R), a receptor tyrosine kinase. Activation of this receptor can influence intracellular pathways including PI3K/Akt and MAPK signalling. These networks are widely investigated in cell proliferation, differentiation, metabolism and survival research.
Key Research Areas
IGF-1 LR3 research has examined several areas of experimental biology, including:
Findings from in-vitro or animal models should not be interpreted as established therapeutic outcomes in humans.
Why Researchers Study IGF-1 LR3
One important characteristic of IGF-1 LR3 is its altered relationship with IGF-binding proteins. Native IGF-1 interacts with several IGF-binding proteins that regulate its distribution and biological availability.
The structural modifications in Long R3 IGF-1 reduce its affinity for certain IGF-binding proteins, making the analogue particularly interesting for controlled studies of IGF-1R-mediated signalling.
Researchers may therefore use IGF-1 LR3 when examining receptor activation, downstream signalling and growth-factor biology in experimental systems.
Key Research Areas at a Glance
IGF-1 LR3 in Australia
Researchers looking for IGF-1 LR3 Australia should consider analytical documentation and batch traceability alongside price and availability.
Before purchasing IGF-1 LR3 online, laboratories should confirm the vial specification, current stock status, available CoA and testing methodology. Australian researchers should also consider applicable regulatory, institutional and import requirements when sourcing research peptides.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Analytical documentation is important when sourcing IGF-1 LR3 for laboratory research. Researchers should review the product’s batch-specific documentation to confirm the nominal vial quantity, measured purity and analytical identity.
Where available, techniques such as HPLC and mass spectrometry or LC-MS can provide information about purity and molecular identity. A Certificate of Analysis should relate to the specific batch supplied rather than being treated as evidence of therapeutic safety or effectiveness.
Storage & Handling
Storage and Laboratory Handling
IGF-1 LR3 should be handled according to the verified storage conditions supplied with the specific research batch.
- Lyophilised Storage: Refer to the product label, batch documentation or supplier’s validated storage specification.
- After Reconstitution: Follow the laboratory’s validated protocol and batch documentation. A post-reconstitution stability period should not be assumed unless supporting stability data are available.
Reconstitution calculator: IGF-1 LR3 1mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
IGF-1 LR3 1mg: Frequently Asked Questions
IGF-1 LR3 is a modified IGF-1 analogue developed for experimental investigation of IGF-related receptor and cellular signalling.
It is investigated primarily through its interaction with IGF-1R and subsequent signalling pathways, including PI3K/Akt and MAPK.
Its modified sequence alters its interactions with IGF-binding proteins, distinguishing it experimentally from endogenous IGF-1.
Research includes IGF signalling, cell proliferation, differentiation, metabolic pathways and endocrine biology.
Purity and testing should be confirmed from the documentation accompanying the specific batch.
Researchers should check whether a batch-specific CoA is supplied and review the analytical results before laboratory use.
Follow the verified storage instructions provided for the specific batch rather than relying on generic peptide-storage recommendations.
Availability depends on the research supplier and current stock. Researchers should assess batch testing, CoA documentation, product specifications and applicable Australian requirements before ordering.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Reviews
There are no reviews yet.